$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Nov 26, 2025)
-
Market Cap
-
P/E Ratio
-
EPS
$0.00
52 Week High
$0.00
52 Week Low
NONE
Sector
Sector: NONE
Industry: NONE
YD Bio Limited is a biotechnology company headquartered in Taipei, Taiwan, focused on the development and commercialization of innovative therapeutics and diagnostics. Leveraging cutting-edge research and technology, YD Bio aims to address unmet medical needs in various therapeutic areas, including oncology and autoimmune diseases. With a strong commitment to scientific excellence and a robust pipeline of products, the company is well-positioned to capitalize on growth opportunities within the rapidly evolving biotech landscape.
LPTX
NVDA
VHAI
BYND
KTTA
ZYXI
AMBR
BITF
PLUG
NIO
IPG
ASST
CLSK
AAL
TSLA
CIFR
SOFI
INTC
GOOGL
ADAP
MARA
WULF
HOOD
KVUE
F
AMD
SNDK
WBD
DNN
TLRY
BTBT
GRAB
RIG
PLTR
PFE
HBAN
IVP
AGNC
BAC
CCL
SNAP
GOOG
RGTI
AVGO
VALE
NFLX
MTSR
PLTD
T
IREN
ORCL
NTNX
MSFT
ITUB
DVLT
PCG
NOK
CMG
HBI
CAN
HPQ
APLD
LPTX
NVDA
VHAI
BYND
KTTA
ZYXI
AMBR
BITF
PLUG
NIO
IPG
ASST
CLSK
AAL
TSLA
CIFR
SOFI
INTC
GOOGL
ADAP
MARA
WULF
HOOD
KVUE
F
AMD
SNDK
WBD
DNN
TLRY
BTBT
GRAB
RIG
PLTR
PFE
HBAN
IVP
AGNC
BAC
CCL
SNAP
GOOG
RGTI
AVGO
VALE
NFLX
MTSR
PLTD
T
IREN
ORCL
NTNX
MSFT
ITUB
DVLT
PCG
NOK
CMG
HBI
CAN
HPQ
APLD